Seong Jang

1PUBLICATIONS
0CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|May 06, 2023
Comparative biochemical kinase activity analysis identifies rivoceranib as a highly selective VEGFR2 inhibitor.

Seong Jang, Bill Strickland, Lynda Finis

Pageof 1

Frequent Collaborators